Yihua Health Medical Co., Ltd. (hereinafter referred to as "the Company") and its directors, supervisors, and senior management guarantee that the content of this announcement is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.
I. Meeting Convening and Attendance
The 2022 Annual General Meeting of Yihua Health Medical Co., Ltd. was held in a combination of on-site and online voting. The on-site meeting took place on May 19, 2023, at 2:00 PM in the conference room on the fourth floor of Yihua Health, located in the Laiwu Linghai Industrial Zone, Chenghai District, Shantou City, Guangdong Province. Online voting was conducted from 9:15 AM to 9:25 AM, 9:30 AM to 11:30 AM, and 1:00 PM to 3:00 PM on May 19, 2023, through the Shenzhen Stock Exchange trading system and the internet voting system. A total of 70 shareholders participated in the meeting, representing 160,070,118 shares, accounting for 18.2375% of the total shares of the listed company. Among them, 2 shareholders voted on-site, representing 156,028,168 shares (17.7770%), while 68 shareholders voted online, representing 4,041,950 shares (0.4605%). The meeting was convened by the Company's board of directors, attended by directors, supervisors, and the board secretary, with senior management present. Lawyers Liu Zhuoling and Zhang Tengfei from Beijing Jincheng Tongda (Shenzhen) Law Firm attended the meeting to provide witness and legal opinions. The convening and procedures of this general meeting complied with the Company Law, Rules of Shareholders' Meetings, Guidelines for the Standardized Operation of Listed Companies on the Shenzhen Stock Exchange, and relevant provisions of the Company's articles of association.
II. Proposal Review
The shareholders reviewed and approved the following proposals through a combination of on-site and online voting:
(1) Approval of the Company's 2022 Annual Report and Summary
Voting results: 158,079,718 shares in favor (98.7565%); 1,753,200 shares against (1.0953%); 237,200 shares abstained (0.1482%). The proposal was approved. Among minority investors, 2,051,550 shares voted in favor (50.7564%); 1,753,200 shares against (43.3751%); 237,200 shares abstained (5.8685%).
(2) Approval of the Company's 2022 Board Work Report
Voting results: 158,777,818 shares in favor (99.1927%); 1,055,100 shares against (0.6591%); 237,200 shares abstained (0.1482%). The proposal was approved. Among minority investors, 2,749,650 shares voted in favor (68.0278%); 1,055,100 shares against (26.1037%); 237,200 shares abstained (5.8685%).